Navigation Links
Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
Date:11/16/2010

;

The data from this abstract demonstrated that RB006 (1mg/kg, IV) results in consistent and near complete inhibition of FIX in patients with ACS with stable anti-coagulation throughout catheterization (PCI).  These findings further validate the dosing of RB006 for Regado's ongoing and planned clinical trials.

The abstract is coauthored by Thomas J. Povsic, MD, Ph.D., Richard A. Becker, MD, and John H. Alexander, MD, MHS, all from Duke University Medical Center; Christopher P. Rusconi, Ph.D., Steven L. Zelenkofske, D.O., both from Regado Biosciences; and William Wargin, Ph.D., President of PK-PM Associates, LLC; Mauricio G. Cohen, MD, University of Miami Miller School of Medicine; Roxana Mehran, MD, Mount Sinai School of Medicine; Christoph Bode, MD, University of Freiburg, Germany; Joshua Krasnow, MD, Heart Center Research, LLC; and Merrill Krolick, D.O., Heart and Vascular Institute of Florida.  

ABOUT REGADO BIOSCIENCESRegado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, providing a safe and unique approach to personalized medicine.

ABOUT REG1,
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
2. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
3. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
4. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
5. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
6. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
7. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
8. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
9. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
10. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
11. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... --Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... the 27th Annual ROTH Conference on March 10, 2015 ... California . To learn more about the ROTH ... live webcast of the presentation will be available on ...
(Date:3/4/2015)... 2015  Students from Indiana University School of Medicine ... are discovered. Through a partnership with Lilly ... IU School of Medicine are learning about drug development ... different and important roles in bringing new and innovative ... educator, scientific investigator, and health system administrator, I recognize ...
(Date:3/4/2015)... LAKE CITY , March 4, 2015  ECR ... VAR ) is showcasing a full spectrum of ... improve image quality, reduce costs, and enable greater patient ... cone-beam CT imaging systems.  These solutions are on display ... in Vienna, Austria this week.   ...
Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... American Medical Systems® (AMS) (NASDAQ: AMMD), a ... and female pelvic health, today announced it has received ... Welfare (MHLW) to market and distribute its GreenLight HPS® ... Hyperplasia (BPH), or enlarged prostate, in Japan. ...
... 2011 Misonix, Inc. (NASDAQ: MSON ), ... innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic ... applications, announced today that it will present at the ... 2011 at the Le Parker Meridien Hotel in New ...
Cached Medicine Technology:American Medical Systems' GreenLight HPS® Approved for Use in Japan 2Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011 2
(Date:3/4/2015)... is no stranger to drug addiction. The bustling city has ... from the potential threat of Kratom. In a report by ... Kratom is a “drug of concern.” Although Kratom is legally ... Southeast Asia acts as a stimulant in low doses, yet ... similar to heroin withdrawal, and includes tremors, irritation, anxiety, and ...
(Date:3/4/2015)... SIGVARIS proved innovative when ... first compression therapy collection designed exclusively for men. ... USA is proud to announce the launch of three ... Constructed from a unique, extremely fine synthetic fiber, MIDTOWN ... socks and thigh-highs offer a tailored look that is ...
(Date:3/4/2015)... According to a new report published ... the U.S. suffer from gastroesophageal reflux disease (GERD), more ... to control acid production, but these can have side ... the problem and lead to other uncomfortable digestive conditions. ... the lower esophageal sphincter does not function properly. Anti-reflux ...
(Date:3/4/2015)... 04, 2015 In a small ceremony with ... on their new facility in New Port Richey on February ... new facility will allow the Florida drug detox facility ... drug abuse epidemic through treatment and education. “Due to our ... in the United States, we made the decision that expanding ...
(Date:3/4/2015)... 04, 2015 Jeannie Mai, TV personality, fashion ... graces the cover of the print publication. Mai embraces the ... organic when shopping for clothes and personal care products. In ... about her commitment to an organic diet. She mentions, “Having ... only in gymnastics, but also now as I’m a full ...
Breaking Medicine News(10 mins):Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... MINNEAPOLIS / ST. PAUL Minn. (October 28, 2010) ... Medical Center researchers have discovered a correlation between increased ... and the debilitating, involuntary flashbacks triggered by post traumatic ... PTSD through concrete evidence of neural activity, its impact ...
... HealthDay Reporter , THURSDAY, Oct. 28 (HealthDay ... green tea might help protect women from breast cancer, ... conclusion. "We found no overall association between green ... Japanese women who have habitually drunk green tea," said ...
... , WEDNESDAY, Oct. 27 (HealthDay News) -- Children ... increased risk for obesity in adulthood, a new study ... the symptoms of ADHD -- such as inattention, hyperactivity ... obese, according to researchers from Duke University Medical Center, ...
... , WEDNESDAY, Oct. 27 (HealthDay News) The ... are associated with heightened activity on the right side ... research that included 80 people with PTSD (many of ... and 284 people without the condition, researchers used a ...
... , BOSTON--A new oral drug caused dramatic shrinkage of a ... by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute ... England Journal of Medicine . A second patient who ... mutant protein, called ALK (named for the first disease in ...
... A comprehensive review of national opinion polls, including newly released ... for a Democratic congressional candidate in 2010 and those who ... district hold starkly different views of what they want the ... between Democratic and Republican leaders in Congress on this issue. ...
Cached Medicine News:Health News:U of M researchers identify possible key to treating, understanding post-traumatic stress disorder 2Health News:Study Finds Green Tea Offers No Protection From Breast Cancer 2Health News:Children with ADHD Symptoms at Higher Risk of Obesity 2Health News:PTSD Linked to 'Hyperactivity' in Right Brain 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 2Health News:'Smart drug' targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer 3Health News:Prospective voters and the new health care law 2
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
An ideal choice for film photography. The new TRC-50FXC provides 35mm color and Polaroid capability....
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
Medicine Products: